Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial

Abstract Background Digital adherence technologies (DATs) are recommended to support patient-centred, differentiated care to improve tuberculosis (TB) treatment outcomes, but evidence that such technologies improve adherence is limited. We aim to implement and evaluate the effectiveness of smart pil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amare W. Tadesse, Zemedu Mohammed, Nicola Foster, Matthew Quaife, Christopher Finn McQuaid, Jens Levy, Kristian van Kalmthout, Job van Rest, Degu Jerene, Tofik Abdurhman, Hiwot Yazew, Demekech G. Umeta, Demelash Assefa, Gedion T. Weldemichael, Ahmed Bedru, Taye Letta, Katherine L. Fielding
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/120aeeaf4d3c48d7b9cf0a2941115cf7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:120aeeaf4d3c48d7b9cf0a2941115cf7
record_format dspace
spelling oai:doaj.org-article:120aeeaf4d3c48d7b9cf0a2941115cf72021-11-14T12:44:25ZEvaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial10.1186/s12879-021-06833-x1471-2334https://doaj.org/article/120aeeaf4d3c48d7b9cf0a2941115cf72021-11-01T00:00:00Zhttps://doi.org/10.1186/s12879-021-06833-xhttps://doaj.org/toc/1471-2334Abstract Background Digital adherence technologies (DATs) are recommended to support patient-centred, differentiated care to improve tuberculosis (TB) treatment outcomes, but evidence that such technologies improve adherence is limited. We aim to implement and evaluate the effectiveness of smart pillboxes and medication labels linked to an adherence data platform, to create a differentiated care response to patient adherence and improve TB care among adult pulmonary TB participants. Our study is part of the Adherence Support Coalition to End TB (ASCENT) project in Ethiopia. Methods/Design We will conduct a pragmatic three-arm cluster-randomised trial with 78 health facilities in two regions in Ethiopia. Facilities are randomised (1:1:1) to either of the two intervention arms or standard of care. Adults aged ≥ 18 years with drug-sensitive (DS) pulmonary TB are enrolled over 12 months and followed-up for 12 months after treatment initiation. Participants in facilities randomised to either of the two intervention arms are offered a DAT linked to the web-based ASCENT adherence platform for daily adherence monitoring and differentiated response to patient adherence for those who have missed doses. Participants at standard of care facilities receive routine care. For those that had bacteriologically confirmed TB at treatment initiation and can produce sputum without induction, sputum culture will be performed approximately 6 months after the end of treatment to measure disease recurrence. The primary endpoint is a composite unfavourable outcome measured over 12 months from TB treatment initiation defined as either poor end of treatment outcome (lost to follow-up, death, or treatment failure) or treatment recurrence measured 6 months after the scheduled end of treatment. This study will also evaluate the effectiveness, feasibility, and cost-effectiveness of DAT systems for DS-TB patients. Discussion This trial will evaluate the impact and contextual factors of medication label and smart pillbox with a differentiated response to patient care, among adult pulmonary DS-TB participants in Ethiopia. If successful, this evaluation will generate valuable evidence via a shared evaluation framework for optimal use and scale-up. Trial registration: Pan African Clinical Trials Registry PACTR202008776694999, https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12241 , registered on August 11, 2020.Amare W. TadesseZemedu MohammedNicola FosterMatthew QuaifeChristopher Finn McQuaidJens LevyKristian van KalmthoutJob van RestDegu JereneTofik AbdurhmanHiwot YazewDemekech G. UmetaDemelash AssefaGedion T. WeldemichaelAhmed BedruTaye LettaKatherine L. FieldingBMCarticleTuberculosisSmart pillboxMedication labelTrialCluster randomisedPragmaticInfectious and parasitic diseasesRC109-216ENBMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Tuberculosis
Smart pillbox
Medication label
Trial
Cluster randomised
Pragmatic
Infectious and parasitic diseases
RC109-216
spellingShingle Tuberculosis
Smart pillbox
Medication label
Trial
Cluster randomised
Pragmatic
Infectious and parasitic diseases
RC109-216
Amare W. Tadesse
Zemedu Mohammed
Nicola Foster
Matthew Quaife
Christopher Finn McQuaid
Jens Levy
Kristian van Kalmthout
Job van Rest
Degu Jerene
Tofik Abdurhman
Hiwot Yazew
Demekech G. Umeta
Demelash Assefa
Gedion T. Weldemichael
Ahmed Bedru
Taye Letta
Katherine L. Fielding
Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
description Abstract Background Digital adherence technologies (DATs) are recommended to support patient-centred, differentiated care to improve tuberculosis (TB) treatment outcomes, but evidence that such technologies improve adherence is limited. We aim to implement and evaluate the effectiveness of smart pillboxes and medication labels linked to an adherence data platform, to create a differentiated care response to patient adherence and improve TB care among adult pulmonary TB participants. Our study is part of the Adherence Support Coalition to End TB (ASCENT) project in Ethiopia. Methods/Design We will conduct a pragmatic three-arm cluster-randomised trial with 78 health facilities in two regions in Ethiopia. Facilities are randomised (1:1:1) to either of the two intervention arms or standard of care. Adults aged ≥ 18 years with drug-sensitive (DS) pulmonary TB are enrolled over 12 months and followed-up for 12 months after treatment initiation. Participants in facilities randomised to either of the two intervention arms are offered a DAT linked to the web-based ASCENT adherence platform for daily adherence monitoring and differentiated response to patient adherence for those who have missed doses. Participants at standard of care facilities receive routine care. For those that had bacteriologically confirmed TB at treatment initiation and can produce sputum without induction, sputum culture will be performed approximately 6 months after the end of treatment to measure disease recurrence. The primary endpoint is a composite unfavourable outcome measured over 12 months from TB treatment initiation defined as either poor end of treatment outcome (lost to follow-up, death, or treatment failure) or treatment recurrence measured 6 months after the scheduled end of treatment. This study will also evaluate the effectiveness, feasibility, and cost-effectiveness of DAT systems for DS-TB patients. Discussion This trial will evaluate the impact and contextual factors of medication label and smart pillbox with a differentiated response to patient care, among adult pulmonary DS-TB participants in Ethiopia. If successful, this evaluation will generate valuable evidence via a shared evaluation framework for optimal use and scale-up. Trial registration: Pan African Clinical Trials Registry PACTR202008776694999, https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12241 , registered on August 11, 2020.
format article
author Amare W. Tadesse
Zemedu Mohammed
Nicola Foster
Matthew Quaife
Christopher Finn McQuaid
Jens Levy
Kristian van Kalmthout
Job van Rest
Degu Jerene
Tofik Abdurhman
Hiwot Yazew
Demekech G. Umeta
Demelash Assefa
Gedion T. Weldemichael
Ahmed Bedru
Taye Letta
Katherine L. Fielding
author_facet Amare W. Tadesse
Zemedu Mohammed
Nicola Foster
Matthew Quaife
Christopher Finn McQuaid
Jens Levy
Kristian van Kalmthout
Job van Rest
Degu Jerene
Tofik Abdurhman
Hiwot Yazew
Demekech G. Umeta
Demelash Assefa
Gedion T. Weldemichael
Ahmed Bedru
Taye Letta
Katherine L. Fielding
author_sort Amare W. Tadesse
title Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
title_short Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
title_full Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
title_fullStr Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
title_full_unstemmed Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
title_sort evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in ethiopia: a study protocol for a cluster randomised trial
publisher BMC
publishDate 2021
url https://doaj.org/article/120aeeaf4d3c48d7b9cf0a2941115cf7
work_keys_str_mv AT amarewtadesse evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT zemedumohammed evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT nicolafoster evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT matthewquaife evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT christopherfinnmcquaid evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT jenslevy evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT kristianvankalmthout evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT jobvanrest evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT degujerene evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT tofikabdurhman evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT hiwotyazew evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT demekechgumeta evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT demelashassefa evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT gediontweldemichael evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT ahmedbedru evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT tayeletta evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
AT katherinelfielding evaluationofimplementationandeffectivenessofdigitaladherencetechnologywithdifferentiatedcaretosupporttuberculosistreatmentadherenceandimprovetreatmentoutcomesinethiopiaastudyprotocolforaclusterrandomisedtrial
_version_ 1718429029478957056